SurModics SRDX 深 沪
已收盘 11-19 16:00:00 美东时间
42.98
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 42.98
- 总市值 6.15亿
- 52周最高 43.0048
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 25.87
- 委 比 0.00%
- 总股本 1429.76万
- 历史最高 82.35
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.73
- 每 手 1
- 风险率 4.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review
Irenic Capital presses Integer Holdings to refresh its board and consider a sale, arguing the stock trades at a discount amid weak shares and limited visibility.
12-18 23:04
SurModics Completes Merger, Ends Credit Agreement
An update from SurModics ( ($SRDX) ) is now available. On November 19, 2025, Su...
11-20 06:09
Barrington Research Downgrades Surmodics to Underperform
Barrington Research analyst Michael Petusky downgrades Surmodics (NASDAQ:SRDX) from Market Perform to Underperform.
11-15 02:07
美股牛股 | ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%
ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%，Q3业绩超预期及上调财年销售指引>>
11-12 18:55
Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge
A U.S. court denied the FTC's bid to block GTCR's $627 million acquisition of Surmodics, clearing the way for the merger to proceed.
11-12 01:00
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining more than 100 points o...
11-11 23:08
Surmodics surges after court denies injunction to block sale to GTCR
Surmodics (SRDX) soared 49% in premarket trading after a federal court rejected a request by the Federal Trade Commission to block its planned sale to GTCR. Judge Jeffrey Cummings denied the FTC's mo...
11-11 21:27
U.S. Court Denies U.S. Federal Trade Commission's Bid To Block GTCR's Acquisition Of Surmodics
- Reuters Citing Court Hearing
11-11 05:59
Surmodics To Present PROWL Registry Sex-Specific Data From Analysis Of 160 Participants At TCT Symposium On Oct. 28
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific
10-28 04:11
GTCR purchase of Surmodics would hurt medical device market, FTC says
Private equity firm GTCR's planned purchase of medical device coatings firm Surmodics (NASDAQ:SRDX) would harm competition in the market, the Federal Trade Commission said on the first day of a trial ...
08-22 02:43
